Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josef Veselka

Showing results (1-10 of 209) with videos related to

Pageof 21
Sort By:
International Journal of Cardiology|May 12, 2025
Reply to "alcohol septal ablation for obstructive hypertrophic cardiomyopathy: Outdated technique or promising future?"Josef Veselka
JACC. Cardiovascular Interventions|December 2, 2025
Refining Carotid Stenting Through Mesh-Integrated Stent DesignJosef Veselka
American Heart Journal|July 29, 2014
Pre-percutaneous coronary intervention statin therapy: is it necessary?Josef Veselka
JACC. Clinical Electrophysiology|November 24, 2022
Lessons We Learned About Sudden Death in Hypertrophic CardiomyopathyJosef Veselka
Swiss Medical Weekly|August 18, 2024
It has been 30 years since the first alcohol septal ablation for hypertrophic obstructive cardiomyopathy was performedJosef Veselka
The Canadian Journal of Cardiology|September 25, 2019
Hypertrophic Cardiomyopathy Is at Increased Risk of Thromboembolic Events: Deficiencies of CHA<sub>2</sub>DS<sub>2</sub>-VASC Score and How to PredictJosef Veselka
European Heart Journal|October 13, 2006
Improvement of left ventricular diastolic function after alcohol septal ablation for obstructive hypertrophic cardiomyopathy? Yes, of course, butJosef Veselka
Archives of Medical Science : AMS|March 21, 2013
The time has come to move from coronary angiography to physiological assessment of coronary lesionsJosef Veselka
The International Journal of Angiology : Official Publication of the International College of Angiology, Inc|September 30, 2015
Atherosclerotic Plaque Composition Is Still an Almost Unrecognized Factor of Risk Stratification in Patients with Carotid Artery DiseaseJosef Veselka
International Journal of Cardiology|February 14, 2024
Estimating the risk of sudden death in hypertrophic cardiomyopathy might be solved by artificial intelligenceJosef Veselka
Pageof 21

Showing results (1-10 of 209) with videos related to

Sort By:
Pageof 21
International Journal of Cardiology|May 12, 2025
Reply to "alcohol septal ablation for obstructive hypertrophic cardiomyopathy: Outdated technique or promising future?"Josef Veselka
JACC. Cardiovascular Interventions|December 2, 2025
Refining Carotid Stenting Through Mesh-Integrated Stent DesignJosef Veselka
American Heart Journal|July 29, 2014
Pre-percutaneous coronary intervention statin therapy: is it necessary?Josef Veselka
JACC. Clinical Electrophysiology|November 24, 2022
Lessons We Learned About Sudden Death in Hypertrophic CardiomyopathyJosef Veselka
Swiss Medical Weekly|August 18, 2024
It has been 30 years since the first alcohol septal ablation for hypertrophic obstructive cardiomyopathy was performedJosef Veselka
The Canadian Journal of Cardiology|September 25, 2019
Hypertrophic Cardiomyopathy Is at Increased Risk of Thromboembolic Events: Deficiencies of CHA<sub>2</sub>DS<sub>2</sub>-VASC Score and How to PredictJosef Veselka
European Heart Journal|October 13, 2006
Improvement of left ventricular diastolic function after alcohol septal ablation for obstructive hypertrophic cardiomyopathy? Yes, of course, butJosef Veselka
Archives of Medical Science : AMS|March 21, 2013
The time has come to move from coronary angiography to physiological assessment of coronary lesionsJosef Veselka
The International Journal of Angiology : Official Publication of the International College of Angiology, Inc|September 30, 2015
Atherosclerotic Plaque Composition Is Still an Almost Unrecognized Factor of Risk Stratification in Patients with Carotid Artery DiseaseJosef Veselka
International Journal of Cardiology|February 14, 2024
Estimating the risk of sudden death in hypertrophic cardiomyopathy might be solved by artificial intelligenceJosef Veselka
Pageof 21